Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

HPV

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation

New Vax Status

Thimerosal

 

Vaccine Info

2016 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

Components of
DT Vaccines

Excipients Table
Allergens Table
Components Table

 
Indication

To prevent infection with Corynebacterium diphtheriae and Clostridium tetani; use when pertussis vaccine component is contraindicated

Proprietary Name

DT (generic)

Manufacturer

sanofi pasteur

Viability

Inactivated

Microorganism

Corynebacterium diphtheriae and Clostricium tetani

Ages

6 weeks through 6 years (before 7th birthday)

Dosage

0.5 mL

Schedule

5 dose series at 2, 4, 6, 15-18 months and 4-6 years

Route

Intramuscular

Dose form

Suspension

Appearance

Uniform, white and cloudy

Concentration (per 0.5 mL)

Diphtheria, 25 Lf
Tetanus, 5 LF

Preservatives

None

Adjuvant

Aluminum phosphate, 1.5 mg

Excipients

Formaldehyde (residual-free), 100 mcg
Aluminum phosphate, 1.5 mg

Allergens

None

Media

The culture media consist of a tryptic digest of casein, supplemented with cystine, dextrose (Diptheria only), uracil (Tetaus only), maltose, uracil, inorganic salts and vitamins.

Packaging

Single-dose (0.5 mL) vials

Routine Storage

2 to 8 C (36-46 F) - Do Not Freeze

Package Insert Date

June 2013

table updated Sep 2016

This page was last updated on September 21, 2016

2016 Institute for Vaccine Safety